by Walter and Eliza Hall Institute of Medical Research Targeting a “cell survival” protein could be a valuable new approach to treating certain blood cancers associated with Epstein-Barr virus (EBV), according to research resulting from a collaboration between scientists at the Walter and Eliza Hall Institute, Australia and the University of Birmingham, UK. The research team discovered that the protein BCL-XL...
